查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1927683

全球基於 CRISPR 的即時診斷市場：按產品類型、技術類型、檢測方法、應用、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032 年）

CRISPR-based POC Diagnostics Market, By Product Type, By Technology Type, By Detection Method, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，基於 CRISPR 的即時診斷市場規模將達到 5.0512 億美元，從 2025 年到 2032 年的複合年成長率將達到 15.85%。

基於 CRISPR 的照護現場(POC) 技術是一種快速分子檢測解決方案，它利用 CRISPR 基因編輯酶以高特異性和靈敏度檢測病原體。感染疾病管理領域，特別是呼吸道疾病和新興感染疾病，對分散式快速診斷的需求日益成長，推動了市場成長。機會包括開發多重和無需儀器的檢測方法，從而縮短檢測週期，這對於資源匱乏和遠端醫療機構至關重要。值得關注的趨勢包括將微流體技術與攜帶式讀數器結合，以提高準確性和便利性。然而，監管複雜性、生產擴充性以及缺乏長期臨床檢驗等挑戰阻礙了其在常規診斷和大規模篩檢計畫中的廣泛應用。

基於 CRISPR 的即時診斷市場動態

在醫療機構中推廣快速、分散式診斷檢測的應用

醫院、診所和遠端醫療機構對快速、分散式診斷檢測的日益普及，推動了基於 CRISPR 技術的照護現場(POC) 技術的需求成長。這些診斷技術在實現及時、準確的疾病檢測方面發揮著至關重要的作用。隨著醫療系統越來越重視早期診斷、疫情控制和個人化治療，醫療服務提供者需要能夠在中心實驗室之外部署的高靈敏度和高特異性檢測解決方案。基於 CRISPR 技術的 POC 診斷能夠快速檢測病原體、遺傳標記和傳染性病原體，從而滿足了此需求，可在患者就診點或附近進行檢測。急診護理、感染疾病控制和公共衛生監測領域對快速診斷結果的日益依賴，正在加速該技術的應用。尤其是在基層醫療和資源匱乏的環境中，對攜帶式、易用型診斷工具的需求，促使製造商開發出體積更小、對設備依賴性更低的 CRISPR 平台，同時確保檢測的準確性。此外，感染疾病疫情日益頻繁的凸顯了擴充性、分散式檢查解決方案的重要性，進一步推動了市場成長。例如，近期全球健康危機期間快速分子檢測的廣泛應用，凸顯了即時診斷（POC）在減少診斷延誤方面的價值。此外，POC檢測在篩檢、監測和居家照護中的廣泛應用，進一步凸顯了對可靠、快速且易於使用的基於CRISPR技術的診斷解決方案的迫切需求。

基於 CRISPR 的即時診斷市場：細分分析

全球基於 CRISPR 的即時診斷市場按產品類型、技術類型、檢測方法、應用和地區進行細分。

根據產品類型，市場可分為四大類：診斷試劑盒、試劑和酵素、一次性試劑盒以及檢測板。診斷試劑盒憑藉其直接的臨床應用價值和在照護現場環境中的易用性，佔據市場主導。試劑和酵素位居第二，這主要得益於市場對檢測方法開發、客製化和重複檢測應用（尤其是用於確定靈敏度和特異性的CRISPR相關酶）的持續需求。一次性試劑盒的重要性日益凸顯，因為人們越來越關注無污染的單次使用檢測形式，這類形式能夠簡化工作流程，並支持大規模篩檢和遠端醫療環境中的擴充性。檢測板的普及得益於對在單次檢測中多重檢測多種病原體和生物標記的需求，但其開發複雜性和監管要求目前限制了其廣泛應用。總而言之，這些細分市場反映了市場正朝著整合、擴充性且快速的基於CRISPR的即時檢測診斷解決方案轉變。

根據技術類型，市場可分為四個細分領域：CRISPR-Cas9、CRISPR-Cas12、CRISPR-Cas13 和多重 CRISPR 系統。 CRISPR-Cas12 憑藉其卓越的靈敏度和適用於快速、分散式診斷應用的優勢，佔據市場主導地位。 CRISPR-Cas13 則位居第二，其優勢在於能夠標靶化RNA，使其特別適用於檢測臨床相關的 RNA 病毒和感染疾病。多重 CRISPR 系統由於對在單次檢測中同時檢測多種病原體或基因靶點的需求日益成長而逐漸普及，但目前檢測的複雜性和最佳化方面的挑戰限制了其應用。 CRISPR-Cas9 則位居第二，因為它更應用於基因編輯而非診斷，且缺乏訊號放大功能，因此不適用於快速即時檢測應用。總體而言，技術優先級反映了其效能、速度以及與分散式診斷平台整合的便利性。

基於 CRISPR 的即時診斷市場—區域分析

基於CRISPR技術的照護現場（POC）市場在普及率和成長率方面呈現顯著的區域差異。北美目前主導全球市場，這得益於其諸多優勢，例如先進的醫療基礎設施、大量的研發投入以及生物技術公司和學術研究機構的集中，尤其是在美國，這些優勢正在加速CRISPR診斷平台的商業化進程。

歐洲佔據第二大佔有率，這得益於強大的公共醫療保健資金、德國、英國和法國等國的合作研究生態系統，以及 CRISPR 檢測方法日益融入臨床工作流程。

亞太地區預計將實現最高成長率，主要得益於醫療保健支出增加、政府對生物技術創新的支持，以及中國、印度、日本和東南亞地區快速診斷技術的日益普及。

策略性產業趨勢支撐著該地區的發展勢頭，例如印度生物技術公司 CrisprBits 與 Molbio Diagnostics 建立戰略合作夥伴關係，開發和商業化 POC CRISPR 測試，提高其在區域和全球市場的可及性。

基於 CRISPR 的即時診斷市場—國家分析

基於 CRISPR 的即時診斷 (POC) 市場在國家層面的發展趨勢反映了醫療政策重點、投資環境和創新生態系統的差異。美國憑藉強大的生物技術研發資金、對新型診斷技術的監管支持以及 CRISPR 平台的早期商業化，在全球處於領先地位，從而獲得了較高的市場佔有率並在臨床環境中得到廣泛應用。在歐洲，德國、英國和法國等國家的成長速度僅次於美國，這得益於合作研究網路以及與尋求快速、準確診斷工具的醫療系統的整合。亞太市場，尤其是中國、印度和日本，由於感染疾病負擔日益加重、生物技術投資不斷成長以及醫療基礎設施的不斷完善，正經歷著快速的市場擴張，預計這將推動這些國家快速採用 CRISPR 即時診斷技術。

策略性舉措包括 OraSure Technologies 收購美國 Sherlock Biosciences，這將擴大其 CRISPR 診斷產品；以及 CrisprBits 與印度 Molbio Diagnostics 建立戰略合作夥伴關係，共同開發和部署面向國內和國際市場的 POC CRISPR 測試。

目錄

第1章 CRISPR技術即時診斷市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 基於CRISPR技術的即時診斷市場主要趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 基於 CRISPR 的即時診斷市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

5. 基於 CRISPR 的即時診斷市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：基於CRISPR技術的即時診斷市場概況

  • 基於 CRISPR 的即時診斷市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 基於 CRISPR 的即時診斷市場（按產品類型分類）

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 診斷試劑盒
    • 試劑和酶
    • 免洗墨水匣
    • 檢測組

8. 基於 CRISPR 的即時診斷市場（按技術類型分類）

  • 概述
    • 細分市場佔有率分析：依技術類型分類
    • CRISPR-Cas9
    • CRISPR-Cas12
    • CRISPR-Cas13
    • 多重CRISPR系統

9. 基於 CRISPR 的即時診斷市場（按檢測方法分類）

  • 概述
    • 細分市場佔有率分析：依檢測方法
    • 基於螢光的檢測
    • 比色檢測
    • 電化學檢測
    • 側向流動檢測

10. 基於 CRISPR 的即時診斷市場（按應用分類）

  • 概述
    • 細分市場佔有率分析：按應用
    • 感染疾病檢測
    • 遺傳疾病篩檢
    • 腫瘤診斷
    • 抗生素抗藥性檢測

11. 各地區基於 CRISPR 的即時診斷市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析－基於 CRISPR 的即時診斷產業

  • 競爭格局分析
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Abbott Laboratories
    • Agilent Technologies
    • AstraZeneca
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Caspr Biotech
    • Danaher Corporation
    • Detect Inc.
    • Hologic
    • Illumina
    • Lucira Health
    • Mammoth Biosciences
    • Merck KGaA
    • Qiagen
    • QuidelOrtho
    • Roche Diagnostics
    • Sherlock Biosciences
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Twist Bioscience
    • Others

第13章：分析師視角360度分析

簡介目錄
Product Code: ANV5957

CRISPR-based POC Diagnostics Market size was valued at US$ 505.12 Million in 2024, expanding at a CAGR of 15.85% from 2025 to 2032.

CRISPR-based point-of-care (POC) diagnostics are rapid molecular testing solutions that leverage CRISPR gene-editing enzymes for highly specific and sensitive detection of pathogens. Rising demand for decentralized, fast diagnostics in infectious disease management, particularly for respiratory and emerging diseases, is driving market growth. Opportunities lie in developing multiplexed and instrument-free assays with shorter turnaround times, essential for use in low-resource and remote healthcare settings. A prominent trend is the integration of CRISPR diagnostics with microfluidics and portable readers to enhance accuracy while improving usability. However, challenges such as regulatory complexity, scalability of manufacturing, and limited long-term clinical validation restrain widespread adoption in routine diagnostics and large-scale screening programs.

CRISPR-based POC Diagnostics Market- Market Dynamics

Increasing adoption of rapid, decentralized diagnostic testing across healthcare settings

The increasing adoption of rapid, decentralized diagnostic testing across hospitals, clinics, and remote healthcare settings is significantly driving demand for CRISPR-based point-of-care (POC) diagnostics, which play a critical role in enabling timely and accurate disease detection. As healthcare systems place greater emphasis on early diagnosis, outbreak control, and personalized treatment, providers require highly sensitive and specific testing solutions that can be deployed outside centralized laboratories. CRISPR-based POC diagnostics address this need by enabling rapid molecular detection of pathogens, genetic markers, and infectious agents at or near the patient site. The growing reliance on fast-turnaround diagnostics in emergency care, infectious disease management, and public health surveillance is accelerating adoption. In particular, the demand for portable and easy-to-use diagnostic tools in primary care and low-resource settings is pushing manufacturers to develop compact, instrument-light CRISPR platforms without compromising accuracy. Moreover, the rising frequency of infectious disease outbreaks has highlighted the importance of scalable and decentralized testing solutions, further supporting market growth. For instance, increased use of rapid molecular tests during recent global health emergencies demonstrated the value of point-of-care diagnostics in reducing diagnostic delays. Additionally, the expanding use of POC testing in screening, surveillance, and home-based care is reinforcing the need for reliable, fast, and user-friendly CRISPR-based diagnostic solutions.

CRISPR-based POC Diagnostics Market- Segmentation Analysis:

The Global CRISPR-based POC Diagnostics Market is segmented on the basis of Product Type, Technology Type, Detection Method, Application, and Region.

The market is segmented into four categories based on product type: diagnostic kits, reagents & enzymes, disposable cartridges, and assay panels. Among these, the diagnostic kits segment dominates the market due to its direct clinical applicability and ease of use in point-of-care settings. Reagents & Enzymes rank second, driven by continuous demand from assay development, customization, and repeated test usage, particularly CRISPR-associated enzymes that determine sensitivity and specificity. Disposable Cartridges follow, gaining importance due to rising emphasis on contamination-free, single-use testing formats that simplify workflows and support scalability in mass screening and remote healthcare environments. Assay Panels rank next, as their adoption is growing with demand for multiplex detection of multiple pathogens or biomarkers in a single test, though higher development complexity and regulatory requirements currently limit widespread uptake. Collectively, these segments reflect a shift toward integrated, scalable, and rapid CRISPR-based POC diagnostic solutions.

The market is categorized into four segments based on technology type: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, and multiplex CRISPR systems. The CRISPR-Cas12 segment leads the market, driven by its superior sensitivity and suitability for rapid, decentralized diagnostic applications. CRISPR-Cas13 ranks second, driven by its RNA-targeting capability, making it particularly suitable for detecting RNA viruses and infectious diseases with high clinical relevance. Multiplex CRISPR Systems follow, gaining traction as demand increases for simultaneous detection of multiple pathogens or genetic targets in a single test, although assay complexity and optimization challenges currently moderate adoption. CRISPR-Cas9 ranks next, as it is more widely used in gene editing than diagnostics and lacks inherent signal amplification features, limiting its suitability for rapid POC applications. Overall, technological prioritization reflects performance, speed, and ease of integration into decentralized diagnostic platforms.

CRISPR-based POC Diagnostics Market- Geographical Insights

The CRISPR-based point-of-care (POC) diagnostics market exhibits significant regional variation in adoption and growth rates. North America currently dominates the global landscape, benefiting from advanced healthcare infrastructure, substantial R&D investment, and a strong concentration of biotechnology companies and academic research institutions, particularly in the United States, which accelerates the commercialization of CRISPR diagnostic platforms.

Europe holds the second-largest share, supported by robust public health funding, collaborative research ecosystems in countries such as Germany, the UK, and France, and increasing integration of CRISPR assays into clinical workflows.

The Asia-Pacific region is projected to experience the fastest growth rate, driven by rising healthcare expenditure, government support for biotechnology innovation, and expanding use of rapid diagnostics across China, India, Japan, and Southeast Asia.

Strategic industry developments underscore regional momentum. For instance, Indian biotech firm CrisprBits entered a strategic collaboration with Molbio Diagnostics to develop and commercialize POC CRISPR tests, enhancing accessibility in local and global markets.

CRISPR-based POC Diagnostics Market- Country Insights

Country-level dynamics in the CRISPR-based point-of-care (POC) diagnostics market reflect differing healthcare priorities, investment climates, and innovation ecosystems. The United States leads globally, driven by strong biotech R&D funding, regulatory support for novel diagnostics, and early commercialization of CRISPR platforms, resulting in significant market share and adoption in clinical settings. Europe, with countries such as Germany, the United Kingdom, and France, follows closely, supported by collaborative research networks and integration into healthcare systems seeking rapid, accurate diagnostic tools. Asia-Pacific markets, notably China, India, and Japan, are fast expanding due to rising infectious disease burdens, increased biotech investment, and growing healthcare infrastructure, positioning these nations for rapid POC CRISPR adoption.

Strategic developments include the acquisition of Sherlock Biosciences by OraSure Technologies in the US to broaden CRISPR diagnostic offerings, and a strategic collaboration between India's CrisprBits and Molbio Diagnostics to co-develop and deploy POC CRISPR tests domestically and internationally.

CRISPR-based POC Diagnostics Market- Competitive Landscape:

The competitive landscape of the CRISPR-based point-of-care (POC) diagnostics market is characterized by rapid innovation, strategic partnerships, and consolidation among key biotechnology and diagnostics firms. Leading players such as Mammoth Biosciences, OraSure Technologies (via Sherlock Biosciences), Caspr Biotech, Integrated DNA Technologies (IDT), and GenScript are actively developing and commercializing CRISPR-based diagnostic platforms that combine high sensitivity with decentralized usability. Competitive differentiation is achieved through assay performance, patent portfolios, and integration with portable devices. Market activity includes acquisitions that strengthen technological capabilities and accelerate time-to-market; notably, Sherlock Biosciences acquired Sense Bio detection to integrate instrument-free molecular test hardware with its CRISPR technology, broadening its point-of-care portfolio.

Collaborations also enhance competitiveness, such as strategic alliances between CrisprBits and Molbio Diagnostics to co-develop and distribute rapid POC tests, expanding market reach and accelerating adoption in diverse healthcare settings.

Recent Developments:

In August 2023, CrisprBits entered a strategic collaboration with Molbio Diagnostics to jointly develop and launch CRISPR-based point-of-care (POC) tests, combining CrisprBits' PathCrisp platform with Molbio's manufacturing and distribution network to deliver rapid, affordable diagnostics globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies
  • AstraZeneca
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Caspr Biotech
  • Danaher Corporation
  • Detect Inc.
  • Hologic
  • Illumina
  • Lucira Health
  • Mammoth Biosciences
  • Merck KGaA
  • Qiagen
  • QuidelOrtho
  • Roche Diagnostics
  • Sherlock Biosciences
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Twist Bioscience
  • Others

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Kits
  • Reagents & Enzymes
  • Disposable Cartridges
  • Assay Panels

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • CRISPR-Cas9
  • CRISPR-Cas12
  • CRISPR-Cas13
  • Multiplex CRISPR Systems

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032

  • Fluorescence-Based Detection
  • Colorimetric Detection
  • Electrochemical Detection
  • Lateral Flow Readout

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Detection
  • Genetic Disorder Screening
  • Oncology Diagnostics
  • Antimicrobial Resistance Testing

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR-based POC Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR-based POC Diagnostics Market Snippet by Product Type
    • 2.1.2. CRISPR-based POC Diagnostics Market Snippet by Technology Type
    • 2.1.3. CRISPR-based POC Diagnostics Market Snippet by Detection Method
    • 2.1.4. CRISPR-based POC Diagnostics Market Snippet by Application
    • 2.1.5. CRISPR-based POC Diagnostics Market Snippet by Country
    • 2.1.6. CRISPR-based POC Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR-based POC Diagnostics Key Market Trends

  • 3.1. CRISPR-based POC Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR-based POC Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR-based POC Diagnostics Market Opportunities
  • 3.4. CRISPR-based POC Diagnostics Market Future Trends

4. CRISPR-based POC Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR-based POC Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR-based POC Diagnostics Market Landscape

  • 6.1. CRISPR-based POC Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR-based POC Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Diagnostic Kits
    • 7.1.3. Reagents & Enzymes
    • 7.1.4. Disposable Cartridges
    • 7.1.5. Assay Panels

8. CRISPR-based POC Diagnostics Market - By Technology Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology Type, 2024 & 2032 (%)
    • 8.1.2. CRISPR-Cas9
    • 8.1.3. CRISPR-Cas12
    • 8.1.4. CRISPR-Cas13
    • 8.1.5. Multiplex CRISPR Systems

9. CRISPR-based POC Diagnostics Market - By Detection Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
    • 9.1.2. Fluorescence-Based Detection
    • 9.1.3. Colorimetric Detection
    • 9.1.4. Electrochemical Detection
    • 9.1.5. Lateral Flow Readout

10. CRISPR-based POC Diagnostics Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Infectious Disease Detection
    • 10.1.3. Genetic Disorder Screening
    • 10.1.4. Oncology Diagnostics
    • 10.1.5. Antimicrobial Resistance Testing

11. CRISPR-based POC Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. CRISPR-based POC Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. CRISPR-based POC Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. CRISPR-based POC Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. CRISPR-based POC Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. CRISPR-based POC Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- CRISPR-based POC Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Agilent Technologies
    • 12.2.3. AstraZeneca
    • 12.2.4. Becton, Dickinson and Company
    • 12.2.5. Bio-Rad Laboratories
    • 12.2.6. Caspr Biotech
    • 12.2.7. Danaher Corporation
    • 12.2.8. Detect Inc.
    • 12.2.9. Hologic
    • 12.2.10. Illumina
    • 12.2.11. Lucira Health
    • 12.2.12. Mammoth Biosciences
    • 12.2.13. Merck KGaA
    • 12.2.14. Qiagen
    • 12.2.15. QuidelOrtho
    • 12.2.16. Roche Diagnostics
    • 12.2.17. Sherlock Biosciences
    • 12.2.18. Siemens Healthineers
    • 12.2.19. Thermo Fisher Scientific
    • 12.2.20. Twist Bioscience
    • 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us